Xu L - Search Results

1

Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer.

Xu L, Duda DG, di Tomaso E, Ancukiewicz M, Chung DC, Lauwers GY, Samuel R, Shellito P, Czito BG, Lin PC, Poleski M, Bentley R, Clark JW, Willett CG, Jain RK. Xu L, et al. Cancer Res. 2009 Oct 15;69(20):7905-10. doi: 10.1158/0008-5472.CAN-09-2099. Epub 2009 Oct 13. Cancer Res. 2009. PMID: 19826039 Free PMC article.

2

Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1/2 MAPK signaling pathway: mechanism of low pH-induced VEGF.

Xu L, Fukumura D, Jain RK. Xu L, et al. J Biol Chem. 2002 Mar 29;277(13):11368-74. doi: 10.1074/jbc.M108347200. Epub 2001 Dec 11. J Biol Chem. 2002. PMID: 11741977 Free article.

3

Tumour biology: herceptin acts as an anti-angiogenic cocktail.

Izumi Y, Xu L, di Tomaso E, Fukumura D, Jain RK. Izumi Y, et al. Among authors: xu l. Nature. 2002 Mar 21;416(6878):279-80. doi: 10.1038/416279b. Nature. 2002. PMID: 11907566

4

Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts.

Bockhorn M, Tsuzuki Y, Xu L, Frilling A, Broelsch CE, Fukumura D. Bockhorn M, et al. Among authors: xu l. Clin Cancer Res. 2003 Sep 15;9(11):4221-6. Clin Cancer Res. 2003. PMID: 14519649

5

Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis.

Fukumura D, Ushiyama A, Duda DG, Xu L, Tam J, Krishna V, Chatterjee K, Garkavtsev I, Jain RK. Fukumura D, et al. Among authors: xu l. Circ Res. 2003 Oct 31;93(9):e88-97. doi: 10.1161/01.RES.0000099243.20096.FA. Epub 2003 Oct 2. Circ Res. 2003. PMID: 14525808 Free PMC article.

6

Hypoxia-induced activation of p38 mitogen-activated protein kinase and phosphatidylinositol 3'-kinase signaling pathways contributes to expression of interleukin 8 in human ovarian carcinoma cells.

Xu L, Pathak PS, Fukumura D. Xu L, et al. Clin Cancer Res. 2004 Jan 15;10(2):701-7. doi: 10.1158/1078-0432.ccr-0953-03. Clin Cancer Res. 2004. PMID: 14760093

7

The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis.

Garkavtsev I, Kozin SV, Chernova O, Xu L, Winkler F, Brown E, Barnett GH, Jain RK. Garkavtsev I, et al. Among authors: xu l. Nature. 2004 Mar 18;428(6980):328-32. doi: 10.1038/nature02329. Nature. 2004. PMID: 15029197

8

Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.

Winkler F, Kozin SV, Tong RT, Chae SS, Booth MF, Garkavtsev I, Xu L, Hicklin DJ, Fukumura D, di Tomaso E, Munn LL, Jain RK. Winkler F, et al. Among authors: xu l. Cancer Cell. 2004 Dec;6(6):553-63. doi: 10.1016/j.ccr.2004.10.011. Cancer Cell. 2004. PMID: 15607960 Free article.

9

NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels.

Kashiwagi S, Izumi Y, Gohongi T, Demou ZN, Xu L, Huang PL, Buerk DG, Munn LL, Jain RK, Fukumura D. Kashiwagi S, et al. Among authors: xu l. J Clin Invest. 2005 Jul;115(7):1816-27. doi: 10.1172/JCI24015. Epub 2005 Jun 9. J Clin Invest. 2005. PMID: 15951843 Free PMC article.

10

Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model.

Xu L, Tong R, Cochran DM, Jain RK. Xu L, et al. Cancer Res. 2005 Jul 1;65(13):5711-9. doi: 10.1158/0008-5472.CAN-04-4313. Cancer Res. 2005. PMID: 15994946

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41,526 results

Search Page

Filters